
Sign up to save your podcasts
Or
Public biotech Pyxis Oncology is taking forward its innovative work on ADCs. President and CEO, Lara Sullivan, explains the company’s journey to find the right investors, and why she believes the markets still have some learning to do when analyzing data from early-stage studies.
5
1212 ratings
Public biotech Pyxis Oncology is taking forward its innovative work on ADCs. President and CEO, Lara Sullivan, explains the company’s journey to find the right investors, and why she believes the markets still have some learning to do when analyzing data from early-stage studies.
117 Listeners
318 Listeners
84 Listeners
40 Listeners
10 Listeners
0 Listeners
3,443 Listeners
1 Listeners
17 Listeners
2,332 Listeners